HYPOTENSION DRUG-INDUCED
Clinical trials for HYPOTENSION DRUG-INDUCED explained in plain language.
Never miss a new study
Get alerted when new HYPOTENSION DRUG-INDUCED trials appear
Sign up with your email to follow new studies for HYPOTENSION DRUG-INDUCED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Which sedative is safer for High-Risk ERCP patients?
Symptom relief CompletedThis study compared two sedatives, dexmedetomidine and propofol, in 100 high-risk patients undergoing ERCP. The goal was to see which drug causes fewer breathing and heart problems. Researchers monitored vital signs closely to find the safer option for these vulnerable patients.
Matched conditions: HYPOTENSION DRUG-INDUCED
Phase: NA • Sponsor: Sisli Hamidiye Etfal Training and Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Calcium before heart drug may prevent blood pressure drop
Symptom relief CompletedThis study tested whether giving calcium before the drug diltiazem can prevent a sudden drop in blood pressure in people with a fast heart rate due to atrial fibrillation or flutter. 92 adults took part. The goal was to make the treatment safer and more comfortable.
Matched conditions: HYPOTENSION DRUG-INDUCED
Phase: PHASE4 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC